Neophore
PITCH
Discovering small molecule drugs that create neoantigens Our approach targets the dynamics of cancer neoantigen evolution through the discovery and design of effective, well-tolerated medicines that will become a key part of the next-generation of cancer immunotherapies.
LATEST INVESTMENT
#Biotech
02.2024
£9.6M
Sixth Element Capital, Claris Ventures, Astellas Venture Management, 3B Future Health Fund, 2investAG & Others
#Biotech
01.2023
£6M
CRT Pioneer Fund, Claris Ventures, 2Invest, 3B Future Health Fund & Astellas Venture Management